Eam Investors, LLC Concert Pharmaceuticals, Inc. Transaction History

Eam Investors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$4.27 - $7.2 $146,554 - $247,118	34,322 Added 4.03%	884,969 $5.93 Million
Q2 2022 Aug 12, 2022	BUY	$2.8 - $6.36 $2.38 Million - $5.41 Million	850,647 New	850,647 $3.58 Million
Q1 2018 May 14, 2018	SELL	$19.24 - $28.03 $671,572 - $978,387	-34,905 Closed	0 $0
Q4 2017 May 21, 2018	SELL	$13.96 - $29.05 $549,004 - $1.14 Million	-39,327 Reduced 52.98%	34,905 $903,000
Q4 2017 Feb 12, 2018	BUY	$13.96 - $29.05 $1.04 Million - $2.16 Million	74,232	74,232 $1.92 Million

Ticker CNCE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,934,600
Description
Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company's lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition. It has s...

Get notified when there are updates to the investment portfolio of Eam Investors, LLC, based on Form 13F filings with the SEC.

Stay updated on Eam Investors, LLC with notifications on news.